XBiotech Inc. News
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
Lion Biotechnologies, XBiotech and Halozyme Therapeutics were among the biotech movers in premarket trading on Friday.
XBiotech No. 2 Executive Resigns, Leaving Struggling Biotech Without Top Operations Chief
XBiotech offered no reason for Thornburg's resignation, but he left two weeks after European regulators issued a preliminary recommendation to reject the application for the company's colon cancer drug Xilonix.
XBiotech Leaves European Meeting 'Disappointed' Over Colon Cancer Drug Rejection
XBiotech's efforts to shade Xilonix's clinical failings amounted to little more than hand waving when it mattered most. European regulators at the oral explanation meeting on Thursday were not fooled.
XBiotech: Four Staph Patients Died in Our Clinical Trial, Nothing to Worry About
XBiotech did its best in a Monday morning press release to explain away the negative study results for an antibody designed to treat Staph infection.
XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes
The XBiotech drug, Xilonix, had no effect on the size of colon cancer tumors with zero complete or partial responses reported in the phase III study.
Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Treasury Yields Jump After Weak $43 Billion 2-Year Auction, Sliding Foreign Demand
The Treasury sold $43 billion in 2-year notes at a high yield of 4.29% - nearly a full percentage point above last month's auction levels.
Economist El-Erian Sees Strong Chance for Recession
But he thinks the Fed must keep raising interest rates to quell inflation. And he expects continued market volatility.
Pound Collapse Puts Dollar Parity, Emergency Bank of England Rate Hikes in Focus
Britain's new government said it will continue focusing on tax cuts and new borrowing to boost growth even as markets push the pound to a record low against the U.S. dollar.
What Happens to Your Credit Card When Interest Rates Rise
With interest rates soaring, credit card consumers may be in for a shock